NDC 0006-5331 – Welireg
Belzutifan 40 mg/1 · Tablet, Film Coated · Oral
Product NDC0006-5331
Product details
- Brand name
- Welireg
- Generic name
- Belzutifan
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA215383
- Marketed since
- August 13, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hypoxia-inducible Factor Inhibitor
Active ingredients
- Belzutifan 40 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0006-5331-01 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-5331-01) | Aug 13, 2021 |
| 0006-5331-58 sample | 1 BOTTLE in 1 CARTON (0006-5331-58) / 90 TABLET, FILM COATED in 1 BOTTLE | Jun 21, 2023 |
| 0006-5331-59 sample | 1 BOTTLE in 1 CARTON (0006-5331-59) / 90 TABLET, FILM COATED in 1 BOTTLE | Jun 21, 2023 |